Stock News
Phio Pharmaceuticals to Participate in Renmark Financial Communications Virtual Non-Deal Roadshow Series
Phio Pharmaceuticals Corp. to Present at the Virtual Non-Deal Roadshow Series Presentation Details Thursday, September 5, 2024 Marlborough, Massachusetts–(Newsfile Corp. – August 29, 2024) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, announced…
Breaking News: Northern Graphite’s Q2 2024 Results Are In! Get the Scoop Here!
Strict Cost Control Measures in Place at Northern Graphite Corporation Preserving Working Capital and Bolstering Balance Sheet Northern Graphite Corporation has recently implemented strict cost control measures in order to preserve working capital and bolster their balance sheet. The company’s focus on cost efficiency is aimed at ensuring sustainable growth and long-term success in the…
KANZHUN LIMITED Increases Share Repurchase Program to US $350 Million: A Heartfelt Move for Investors
Share Repurchase Program: A Sign of Confidence in BOSS Zhipin August 29, 2024 KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), today announced that the Company’s board of directors has authorized a new share repurchase program effective from August 29, 2024 for a 12-month period, under which the Company may additionally repurchase…
Breaking News: Northstar’s Q2 2024 Financial Results Are In! Get Ready to Be Impressed!
Welcome to the Exciting World of Northstar Clean Technologies Inc. Q2 2024 Highlights Received approval and $1.34 million in funding from the Government of Alberta’s TIER Fund Northstar Clean Technologies Inc. has hit a major milestone in the second quarter of 2024 by receiving approval and $1.34 million in funding from the Government of Alberta’s…
Unlocking the Secrets: A Humorous and Quirky Look at Accessing Article 909626 in Multiple Languages
Ensysce Biosciences, Inc. Raises Funds for Innovative Pain Relief Solutions Exciting News from Ensysce Ensysce Biosciences, Inc. has recently made headlines with their announcement of entering into definitive agreements that will provide the company with $5 million in gross proceeds. This funding will support their ongoing efforts to develop innovative solutions for severe pain relief,…
Cheers to Success: A Recap of Pernod Ricard SA’s Q4 2024 Earnings Call
Pernod Ricard SA Q4 2024 Earnings Conference Call Analysis Overview Company Participants: Florence Tresarrieu – IR Alexandre Ricard – Chairman and CEO Hélène de Tissot – EVP, Finance Conference Call Participants: Sanjeet Aujla – UBS Simon Hales – Citi Laurence Whyatt – Barclays Andrea Pistacchi – Bank of America Olivier Nicolai – Goldman Sachs Celine…
Chart Industries and Element Resources Partner on Hydrogen Eco-System Deployment
Chart Industries Announces Partnership with Element Resources Inc. to Advance Clean Energy Solutions ATLANTA, Aug. 29, 2024 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS), a leading global solutions provider to clean energy and industrial gas markets, has announced a new partnership with Element Resources Inc., a leader in green hydrogen production. This collaboration aims…
Unlocking the Power of Accessible Web Design: A Guide to Creating Inclusive and Engaging Websites
Levi & Korsinsky Investigates Syros Pharmaceuticals, Inc. Background Information New York, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Syros Pharmaceuticals, Inc. (“Syros Pharmaceuticals”) (NASDAQ:SYRS) concerning possible violations of federal securities laws. Syros issued a press release on August 12, 2024, announcing that…